| Ident. | Authors (with country if any) | Title |
|---|
| 000172 (2011) |
Anne Marthe Meppelink [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Laura K. Teune [Pays-Bas] ; Teus Van Laar [Pays-Bas] | Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations |
| 000199 (2011) |
Hans-Gert Bernstein ; Mary Johnson ; Robert H. Perry ; Fiona E. N. Lebeau [Royaume-Uni] ; Henrik Dobrowolny ; Bernhard Bogerts ; Elaine K. Perry | Partial loss of parvalbumin‐containing hippocampal interneurons in dementia with Lewy bodies |
| 000225 (2011) |
Ari E. Berman [États-Unis] ; Wai Yee Chan [États-Unis] ; Angela M. Brennan [États-Unis] ; Reno C. Reyes [États-Unis] ; Brittany L. Adler [États-Unis] ; Sang Won Suh [États-Unis] ; Tiina M. Kauppinen [États-Unis] ; Ylva Edling [États-Unis] ; Raymond A. Swanson [États-Unis] | N‐acetylcysteine prevents loss of dopaminergic neurons in the EAAC1−/− mouse |
| 000265 (2011) |
James A. Miller [États-Unis] ; Briana R. Trout [États-Unis] ; Kelly A. Sullivan [États-Unis] ; Russell A. Bialecki [États-Unis] ; Ruth A. Roberts [Royaume-Uni] ; Ronald B. Tjalkens [États-Unis] | Low‐dose 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor‐κB reporter mice prior to loss of dopaminergic neurons |
| 000514 (2010) |
Kevin St. P. Mcnaught [États-Unis] ; Ruth Jnobaptiste [États-Unis] ; Tehone Jackson [États-Unis] ; Toni-Ann Jengelley [États-Unis] | The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease |
| 000518 (2010) |
Federica Agosta [Italie] ; Vladimir S. Kosti [Serbie] ; Sebastiano Galantucci [Italie] ; Šarlota Mesaroš [Italie, Serbie] ; Marina Svetel [Serbie] ; Elisabetta Pagani [Italie] ; Elka Stefanova [Serbie] ; Massimo Filippi [Italie] | The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP‐parkinsonism: a VBM‐DARTEL study |
| 000692 (2010) |
Seung Hun Lee [Corée du Sud] ; Mi Jung Kim [Corée du Sud] ; Beom-Jun Kim [Corée du Sud] ; Sung Reul Kim [Corée du Sud] ; Sail Chun [Corée du Sud] ; Jin Sook Ryu [Corée du Sud] ; Ghi Su Kim [Corée du Sud] ; Myoung Chong Lee [Corée du Sud] ; Jung-Min Koh [Corée du Sud] ; Sun Ju Chung [Corée du Sud] | Homocysteine‐lowering therapy or antioxidant therapy for bone loss in Parkinson's disease |
| 000767 (2010) |
Y. Nishio [Japon] ; K. Hirayama [Japon] ; A. Takeda [Japon] ; Y. Hosokai [Japon] ; T. Ishioka [Japon] ; K. Suzuki [Japon] ; Y. Itoyama [Japon] ; S. Takahashi [Japon] ; E. Mori [Japon] | Corticolimbic gray matter loss in Parkinson’s disease without dementia |
| 000912 (2009) |
David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
| 000A42 (2009) |
Arthur Kummer [Brésil] ; Francisco Cardoso [Brésil] ; Antonio Lucio Teixeira [Brésil] | Loss of Libido in Parkinson's Disease |
| 000B25 (2009) |
Tultul Nayyar [États-Unis] ; Michael Bubser [États-Unis] ; Marcus C. Ferguson [États-Unis] ; M. Diana Neely [États-Unis] ; J. Shawn Goodwin [États-Unis] ; Thomas J. Montine [États-Unis] ; Ariel Y. Deutch [États-Unis] ; Twum A. Ansah [États-Unis] | Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation |
| 000C40 (2008) |
Konstanze F. Winklhofer [Allemagne] ; Jörg Tatzelt [Allemagne] ; Christian Haass [Allemagne] | The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases |
| 000D52 (2008) |
Chun-Hung Lin ; Jui-Yen Huang [Taïwan] ; Cheng-Hsin Ching ; Jih-Ing Chuang [Taïwan] | Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats |
| 000F57 (2007) |
Margaret A. Piggott [Royaume-Uni] ; Clive G. Ballard [Royaume-Uni] ; Elise Rowan [Royaume-Uni] ; Clive Holmes [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; Evelyn Jaros [Royaume-Uni] ; Robert H. Perry [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline |
| 001022 (2007) |
Martin Köllensperger [Autriche] ; Nadia Stefanova [Autriche] ; Markus Reindl [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy |
| 001104 (2007) |
Hiroyuki Kinoshita ; Hirohiko Hirano ; Akihiko Hosoya ; Tadashi Ninomiya ; Hidehiro Ozawa ; Motoji Sawabe ; Yasuyoshi Ouchi ; Masatsune Yamaguchi ; Takayuki Hosoi [Japon] | Case of bone Paget's disease with cheek pain, hearing loss and tremor whose histological findings showed peculiar calcified structures |
| 001226 (2006) |
Ergun Y. Uc [États-Unis] ; Lynn K. Struck [États-Unis] ; Robert L. Rodnitzky [États-Unis] ; Bridget Zimmerman [États-Unis] ; Judith Dobson [États-Unis] ; William J. Evans [États-Unis] | Predictors of weight loss in Parkinson's disease |
| 001362 (2006) |
Rebecca E. Colebrooke [Royaume-Uni] ; Trevor Humby [Royaume-Uni] ; Patrick J. Lynch [Royaume-Uni] ; Daniel P. Mcgowan [Royaume-Uni] ; Jing Xia [Royaume-Uni] ; Piers C. Emson [Royaume-Uni] | Age‐related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease |
| 001457 (2005) |
Kamilla M. Pedersen [Danemark] ; Lisbeth Marner [Danemark] ; Henning Pakkenberg [Danemark] ; Bente Pakkenberg [Danemark] | No global loss of neocortical neurons in parkinson's disease: A quantitative stereological study |
| 001467 (2005) |
Yasuomi Ouchi ; Etsuji Yoshikawa [Japon] ; Yoshimoto Sekine [Japon] ; Masami Futatsubashi [Japon] ; Toshihiko Kanno ; Tomomi Ogusu [Japon] ; Tatsuo Torizuka | Microglial activation and dopamine terminal loss in early Parkinson's disease |
| 001509 (2005) |
Philippe Remy [France] ; Miroslava Doder [France] ; Andrew Lees (neurologue) [Royaume-Uni, France] ; Nora Turjanski [France] ; David Brooks [France] | Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system |
